AdaptHealth (NASDAQ:AHCO – Get Free Report) and Flora Growth (NASDAQ:FLGC – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings and profitability.
Analyst Ratings
This is a breakdown of recent ratings for AdaptHealth and Flora Growth, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| AdaptHealth | 1 | 1 | 5 | 0 | 2.57 |
| Flora Growth | 1 | 0 | 1 | 0 | 2.00 |
AdaptHealth presently has a consensus target price of $13.60, indicating a potential upside of 39.49%. Flora Growth has a consensus target price of $30.00, indicating a potential upside of 266.75%. Given Flora Growth’s higher probable upside, analysts clearly believe Flora Growth is more favorable than AdaptHealth.
Profitability
| Net Margins | Return on Equity | Return on Assets | |
| AdaptHealth | 2.53% | 4.85% | 1.75% |
| Flora Growth | -32.03% | -64.02% | -34.46% |
Institutional & Insider Ownership
82.7% of AdaptHealth shares are held by institutional investors. Comparatively, 36.0% of Flora Growth shares are held by institutional investors. 1.6% of AdaptHealth shares are held by insiders. Comparatively, 2.3% of Flora Growth shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Volatility and Risk
AdaptHealth has a beta of 1.77, meaning that its stock price is 77% more volatile than the S&P 500. Comparatively, Flora Growth has a beta of 1.88, meaning that its stock price is 88% more volatile than the S&P 500.
Valuation & Earnings
This table compares AdaptHealth and Flora Growth”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| AdaptHealth | $3.26 billion | 0.40 | $90.42 million | $0.55 | 17.73 |
| Flora Growth | $57.61 million | 0.11 | -$15.91 million | ($32.49) | -0.25 |
AdaptHealth has higher revenue and earnings than Flora Growth. Flora Growth is trading at a lower price-to-earnings ratio than AdaptHealth, indicating that it is currently the more affordable of the two stocks.
Summary
AdaptHealth beats Flora Growth on 11 of the 14 factors compared between the two stocks.
About AdaptHealth
AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also offers wheelchairs, hospital beds, oxygen concentrators, CPAP masks and related supplies, wound care supplies, diabetes management supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.
About Flora Growth
Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products. It also offers food and beverage, nutraceuticals, cannabis accessories and technology, personal care, and wellness; cannabidiol (CBD) derived products, such as gummies, topicals, tinctures, and vape products; cannabis consumption accessories, personal storage, and travel accessories for the vape and dry herbs. In addition, the company manufactures and distributes pharmaceutical goods and medical cannabis products to treat a variety of health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. The company sells its products under the JustCBD, Vessel, and Phatebo brands. Flora Growth Corp. was incorporated in 2019 and is based in Fort Lauderdale, Florida.
Receive News & Ratings for AdaptHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdaptHealth and related companies with MarketBeat.com's FREE daily email newsletter.
